 |
Top 10 Obesity treatment startups
Updated: April 19, 2024 |
Obesity strartups develop new treatment technologies for Obesity, like gene therapy, stem cells, digital therapy, stomach implants, neurostimulators, new bariatric surgery technologies...
1
Country: USA | Funding: $1B
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
2
Country: Ukraine | Funding: $658.9M
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
3
Country: USA | Funding: $544.8M
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
4
Country: USA | Funding: $290M
Our purpose is to reduce the physical, emotional and economic burdens of obesity as a driver of diseases, creating value for the people we serve and the investors we work for.
Our purpose is to reduce the physical, emotional and economic burdens of obesity as a driver of diseases, creating value for the people we serve and the investors we work for.
5
Country: USA | Funding: $276M
Viome has developed technology aimed at balancing microorganisms in the gut. With Viome, you can fine-tune the function of your gut microbiome with a personalized diet to minimize the production of harmful metabolites and maximize the production of beneficial ones, so that you experience increased energy and general well-being, all while reaching and maintaining a healthy state of balance.
Viome has developed technology aimed at balancing microorganisms in the gut. With Viome, you can fine-tune the function of your gut microbiome with a personalized diet to minimize the production of harmful metabolites and maximize the production of beneficial ones, so that you experience increased energy and general well-being, all while reaching and maintaining a healthy state of balance.
6
Country: USA | Funding: $185.6M
ReShape Lifesciences is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
ReShape Lifesciences is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
7
Country: USA | Funding: $167M
Rivus Pharmaceuticals is dedicated to improving metabolic health by developing controlled metabolic accelerators (CMAs) that treat metabolic disorders, including the tricky nonalcoholic steatohepatitis (NASH), cardio-metabolic diseases and obesity, via weight loss.
Rivus Pharmaceuticals is dedicated to improving metabolic health by developing controlled metabolic accelerators (CMAs) that treat metabolic disorders, including the tricky nonalcoholic steatohepatitis (NASH), cardio-metabolic diseases and obesity, via weight loss.
8
Country: USA | Funding: $161.2M
EnteroMedics is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
EnteroMedics is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
9
Country: USA | Funding: $150.4M
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
10
Country: UK | Funding: $127.5M
Oviva is digitising the treatment of type 2 diabetes and obesity through our unique behaviour change platform.
Oviva is digitising the treatment of type 2 diabetes and obesity through our unique behaviour change platform.
11
Country: USA | Funding: $127.6M
Calibrate is a digital metabolic health business that provides a virtual program for weight loss.
Calibrate is a digital metabolic health business that provides a virtual program for weight loss.
12
Country: USA | Funding: $81.5M
USGI Medical develops technologies to enable incisionless surgeries that treat diseases through the natural passageways of the body. The goal is to reduce the size of the stomach using proprietary tissue anchors using a noninvasive, endoscopic procedure requiring no incisions.
USGI Medical develops technologies to enable incisionless surgeries that treat diseases through the natural passageways of the body. The goal is to reduce the size of the stomach using proprietary tissue anchors using a noninvasive, endoscopic procedure requiring no incisions.
13
Country: USA | Funding: $49.2M
ValenTx has developed the ValenTx endoluminal bypass therapy that requires no surgery, stapling or permanent modification of the obese patient's anatomy.
ValenTx has developed the ValenTx endoluminal bypass therapy that requires no surgery, stapling or permanent modification of the obese patient's anatomy.
14
Country: USA | Funding: $30M
Cloud Health Systems provides consultations and other health services to consumers, first focusing on metabolic health and obesity.
Cloud Health Systems provides consultations and other health services to consumers, first focusing on metabolic health and obesity.
15
Country: USA | Funding: $26.3M
Form Health is a telemedical weight loss company that focuses on individuals dealing with obesity.
Form Health is a telemedical weight loss company that focuses on individuals dealing with obesity.
16
Country: UK | Funding: $17.1M
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
18
Country: USA | Funding: $3.2M
Phenomix Sciences an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases. Its first product tackles obesity with a novel blood-based test that is designed to accurately predict the subtype of obesity with a sensitivity and specificity >90%.
Phenomix Sciences an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases. Its first product tackles obesity with a novel blood-based test that is designed to accurately predict the subtype of obesity with a sensitivity and specificity >90%.
19
Country: USA | Funding: $3.1M
Ilant Health provides treatment for obesity and weight management.
Ilant Health provides treatment for obesity and weight management.
20
Country: USA | Funding: $2.9M
MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells.
MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells.
21
Country: USA | Funding: $1.4M
Adipo Therapeutics is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation.
Adipo Therapeutics is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation.
22
Country: USA
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
23
Country: USA
Phyteau is developing completely safe and effective therapeutics to give people control over their metabolism, blood sugar and weight. Our approach represents a new class of incretin-based therapy for diabetes, obesity and related metabolic conditions like NASH, NAFLD and prediabetes.
Phyteau is developing completely safe and effective therapeutics to give people control over their metabolism, blood sugar and weight. Our approach represents a new class of incretin-based therapy for diabetes, obesity and related metabolic conditions like NASH, NAFLD and prediabetes.
24
Country: Israel
Beck Medical develops NozNoz - personal daily diet companion. It’s an innovative soft wearable nasal insert designed to help you achieve your weight loss goals and maintain the results over time.
Beck Medical develops NozNoz - personal daily diet companion. It’s an innovative soft wearable nasal insert designed to help you achieve your weight loss goals and maintain the results over time.
25
Country: Israel
Zen Eating develops a device that comfortably trains people to stop overeating
Zen Eating develops a device that comfortably trains people to stop overeating
26
Country: UK
CiiTECH is a cannabis biotech company that focuses on discovering, developing and commercializing medical cannabis products for the global market. We do this by partnering and collaborating with leading institutions and companies to realize the full potential of cutting-edge cannabis innovation.
CiiTECH is a cannabis biotech company that focuses on discovering, developing and commercializing medical cannabis products for the global market. We do this by partnering and collaborating with leading institutions and companies to realize the full potential of cutting-edge cannabis innovation.